Personal Activity Intelligence (PAI) Pilot



Status:Recruiting
Conditions:High Blood Pressure (Hypertension), High Cholesterol, Obesity Weight Loss, Peripheral Vascular Disease
Therapuetic Areas:Cardiology / Vascular Diseases, Endocrinology
Healthy:No
Age Range:18 - Any
Updated:11/16/2018
Start Date:October 2, 2018
End Date:December 31, 2019
Contact:David S Drozek, DO
Email:drozek@ohio.edu
Phone:678-447-2509

Use our guide to learn which trials are right for you!

Evaluation of Personal Activity Intelligence (PAI) Score Pilot Study

Pilot study to evaluate the use of the Personal Activity Intelligence (PAI) score in a
clinical setting.

This is a pilot project to evaluate the feasibility of a larger study to evaluate the
effectiveness of Personal Activity Intelligence (PAI) score in patients with chronic disease,
as an adjunct to lifestyle medical therapy.

The PAI score is a proprietary formula developed by PAI Health (PH) to aid physical fitness.
A PAI score calculation uses biometrics obtained via a device that measures heart rate and
steps. For this study, Mio Slice, a commercial wrist worn device will be utilized to obtain
data which will be linked to a smart phone. Data from the smart phone app will be accessed by
PAI Health. Feedback information will be given to the participants to encourage increased
physical activity.

The short-term aim of this study is to evaluate the logistics of utilizing PAI in the patient
setting.

The data obtained from this study will be utilized to devise a larger study to evaluate the
utility of PAI in patients with chronic disease who are receiving lifestyle medical therapy.

Inclusion Criteria:

- Adult patients who are seen by the PI in his lifestyle medicine practice at Muntean
Health Care.

- Participants must own a smart phone and feel comfortable managing apps on their smart
phone.

- Participants must be willing and able to register online with PAI Health (PH)

- Participants must be willing to wear a wrist device around the clock, except when
charging or bathing for 12 weeks.

- Participants must have at least one of the following diagnoses:

- overweight / obesity

- diabetes or prediabetes

- hypertension or pre-hypertension

- abnormal lipids

- cardiovascular disease

Exclusion Criteria:

- Patients with angina or poor exercise tolerance, based on the evaluation by the PI,
will be excluded from the study.
We found this trial at
1
site
Athens, Ohio 45701
Principal Investigator: David S Drozek, DO
Phone: 678-447-2509
?
mi
from
Athens, OH
Click here to add this to my saved trials